1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 5:Results of the Student-Newman-Keuls test for the normal-to-lesion ratio of CBF, OEF, and CMRO2 in the 4 patient subgroups with increasing MCA stenotic severity
rCBF rOEF rCMRO2 Group 1 Group 2 >0.05 >0.05 >0.05 Group 3 <0.05 <0.05 >0.05 Group 4 <0.05 >0.05 >0.05 Group 2 Group 3 <0.05 >0.05 >0.05 Group 4 <0.05 >0.05 >0.05 Group 3 Group 4 >0.05 >0.05 >0.05